Evidence map›Paper›PMID 34339113›Full record

ArticleJournal of the International AIDS Society2021

Individual health behaviours to combat the COVID-19 pandemic: lessons from HIV socio-behavioural science.

Jessica E Haberer, Ariane van der Straten, Steven A Safren, Mallory O Johnson, K Rivet Amico, Carlos Del Rio, Michele Andrasik, Ira B Wilson, Jane M Simoni

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Jessica E HabererCenter for Global Health, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-5845-3190
Ariane van der StratenASTRA Consulting, Kensington, CA, USA.ORCID 0000-0001-8536-648X
Steven A SafrenDepartment of Psychology and Center for HIV and Research in Mental Health, University of Miami, FL, USA.ORCID 0000-0002-0121-0806
Mallory O JohnsonDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-0480-2804
K Rivet AmicoHealth Behavior & Health Education, University of Michigan School of Nursing, Ann Arbor, MI, USA.ORCID 0000-0002-4458-6934
Carlos Del RioDepartment of Global Health, Rollins School of Public Health, Atlanta, GA, USA.ORCID 0000-0002-0153-3517
Michele AndrasikVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID 0000-0003-1952-7825
Ira B WilsonDepartment of Health Services, Policy and Practice, Brown University, Providence, RI, USA.ORCID 0000-0002-0246-738X
Jane M SimoniDepartments of Psychology and Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0002-8711-1576
University of California, San Francisco · USBrown University · USEmory University · USFred Hutch Cancer Center · USHarvard University · USUniversity of Miami · USUniversity of Michigan · USUniversity of Washington · US

Funding

LOC: HIV Vaccine Trials NetworkUM1AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Dan H. Barouch, Lawrence Corey · 2011 to 2026
$1175.6M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Tracking and Evaluation CoreU54GM115677 · NIGMS · BROWN UNIVERSITY · PI ROUNDS, SHARON IRENE SMITH · 2016 to 2025
$45.0M
PPE RequestS10AI174104 · NIAID · FRED HUTCHINSON CANCER CENTER · PI COREY, LAWRENCE · 2023 to 2023
$1.4M
Mentoring and Empowerment in the Context of HIV Care for At-Risk PopulationsK24DA037034 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSON, MALLORY O · 2014 to 2018
$918k
National Institute of Allergy and Infectious Diseases UM1AI068614NIAID NIH HHS P30 AI042853NIAID NIH HHS S10 AI174104NIAID NIH HHS UM1 AI068614NIDA NIH HHS K24 DA037034NIGMS NIH HHS U54 GM115677NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

introductionCOVID-19 parallels HIV in many ways. Socio-behavioural science has been critical in elucidating the context and factors surrounding individual levels of engagement with known effective prevention and treatment tools for HIV, thus offering important lessons for ongoing efforts to combat the COVID-19 pandemic. DISCUSSION: Non-adherence to effective disease mitigation strategies (e.g. condoms for HIV and masks for COVID-19) can be attributed in part to prioritizing comfort, convenience and individual autonomy over public health. Importantly, misinformation can fuel denialism and conspiracies that discredit scientific knowledge and motivate nonadherence. These preferences and the extent to which individuals can act on their preferences may be constrained by the structures and culture in which they live. Both HIV and COVID-19 have been politicized and influenced by evolving recommendations from scientists, clinicians, policymakers and politically motivated organizations. While vaccines are vital for ending both pandemics, their impact will depend on availability and uptake. Four decades of experience with the HIV epidemic have shown that information alone is insufficient to overcome these challenges; interventions must address the underlying, often complex factors that influence human behaviour. This article builds from socio-behavioural science theory and describes practical and successful approaches to enable and support adherence to prevention and treatment strategies, including vaccine adoption. Key methods include reframing tools to enhance motivation, promoting centralized sources of trusted information, strategic development and messaging with and within key populations (e.g. through social media) and appealing to self-empowerment, altruism and informed decision making. Orchestrated evidence-based activism is needed to overcome manipulative politicization, while consistent transparent messaging around scientific discoveries and clinical recommendations are critical for public acceptance and support. Ultimately, the effectiveness of COVID-19 vaccines will depend on our ability to engender trust in the communities most affected.

conclusionsMany lessons learned from socio-behavioural science in the HIV pandemic are applicable to the COVID-19 pandemic. Individual behaviour must be understood within its interpersonal and societal context to address the current barriers to adherence to disease-mitigating strategies and promote an effective response to the COVID-19 pandemic, which is likely to be endured for the foreseeable future.

Indexed as

Health BehaviorBehavioral SciencesCOVID-19COVID-19 VaccinesHIV InfectionsHumansPandemicsPublic HealthSARS-CoV-2COVID-19 Vaccinesbehavioural scienceCOVID-19HIVpublic healthsocial sciencevaccine

Identifiers

PMID34339113
PMCPMC8327691
OpenAlexW3189831296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.